References
- Clase CM, Gao P, Tobe SW, McQueen MJ, Grosshennig A, Teo KK, et al. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study. Ann Intern Med 2011;154(5):310-8. https://doi.org/10.7326/0003-4819-154-5-201103010-00005
- Mule G, Castiglia A, Cusumano C, Scaduto E, Geraci G, Altieri D, et al. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria. Adv Exp Med Biol 2017;956:279-306.
- Inker LA, Levey AS, Pandya K, Stoycheff N, Okparavero A, Greene T. Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient: meta-analysis. Am J Kidney Dis 2014; 64(1):74-85. https://doi.org/10.1053/j.ajkd.2014.02.020
- de Zeeuw D. Unmet need in renal protection-do we need a more comprehensive approach? Contrib Nephrol2011;171:157-60.
- Zhong Y, Deng Y, Chen Y, Chuang PY, Cijiang He J. Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases. Kidney Int 2013;84(6):1108-18. https://doi.org/10.1038/ki.2013.276
- Zhang L, Li P, Xing CY, Zhao JY, He YN, Wang JQ, et al. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial. Am J Kidney Dis 2014;64(1):57-65. https://doi.org/10.1053/j.ajkd.2014.01.431
- Cravedi P, Remuzzi G. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol2013;76(4):516-23. https://doi.org/10.1111/bcp.12104
- Venkat KK. Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment. South Med J 2004 Oct;97(10):969-79. https://doi.org/10.1097/01.SMJ.0000140833.51533.46
- Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Physician 2005 Mar 15;71(6):1153-62.
- Yamagata K, Yamagata Y, Kobayashi M, Koyama A. A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol 1996;45(5):281-8.
- Shen P, Yang X, He L. Effect of Astragali and Angelica particle on proteinuria in Chinese patients with primary glomerulonephritis. J Tradit Chin Med2016 Jun;36(3):299-306. https://doi.org/10.1016/S0254-6272(16)30041-3
- Li M, Wang W, Xue J, Gu Y, Lin S. Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. J Ethnopharmacol 2011;133(2):412-9. https://doi.org/10.1016/j.jep.2010.10.012
- Huang LF, Yao YM, Li JF, Zhang SW, Li WX, Dong N, et al. The effect of Astragaloside IV on immune function of regulatory T cell mediated by high mobility group box 1 protein in vitro. Fitoterapia 2012 Dec;83(8):1514-22. https://doi.org/10.1016/j.fitote.2012.08.019
- Nalbantsoy A, Nesil T, Yilmaz-Dilsiz O, Aksu G, Khan S, Bedir E. Evaluation of the immunomodulatory properties in mice and in vitro anti-inflammatory activity of cycloartane type saponins from Astragalus species. J Ethnopharmacol2012;139(2):574-81. https://doi.org/10.1016/j.jep.2011.11.053